<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2__ )*
BOVIE MEDICAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
10211F 10 0
--------------------------
(CUSIP Number)
Mr. Eric Rainer Bashford Irwin A. Kishner, Esq.
2689 Strang Boulevard Herrick, Feinstein LLP
Yorktown Heights, New York 10598 2 Park Avenue
Tel.: (914) 572-4327 New York, New York 10016
Tel.: (212) 592-1400
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
March 16, 2000
----------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 4 Pages
<PAGE>
_______________________________________________________________________________
CUSIP No. 10211F100 13D Page 2 of 4 Pages
_______________________________________________________________________________
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Eric Rainer Bashford Charitable Remainder Unitrust
______________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
______________________________________________________________________________
3 SEC USE ONLY
______________________________________________________________________________
4 SOURCE OF FUNDS*
______________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
______________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
_______________________________________________________________________________
| |
NUMBER OF | 7 | SOLE VOTING POWER
SHARES | | 904,000
BENEFICIALLY |_____|________________________________________________________
OWNED BY | |
EACH | 8 | SHARED VOTING POWER
REPORTING | | -0-
PERSON |_____|________________________________________________________
WITH | |
| 9 | SOLE DISPOSITIVE POWER
| | 904,000
|_____|________________________________________________________
| |
| 10 | SHARED DISPOSITIVE POWER
| | -0-
_______________|_____|_________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
904,000
______________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
______________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.13%
______________________________________________________________________________
14 TYPE OF REPORTING PERSON*
______________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION
<PAGE>
PART II TO SCHEDULE 13D
This statement constitutes Amendment No. 2 to the statement on Schedule
13D filed with the Securities and Exchange Commission on February 19, 1998 (the
"Original Statement"). All defined terms hereunder have the meanings set forth
in the Original Statement. This Amendment No. 2 reflects certain material
changes in the information set forth in the Original Statement, as amended as of
March 10, 1999, as follows:
Item 1. Security and Issuer
Shares of Common Stock
Bovie Medical Corporation
734 Walt Whitman Road
Suite 207
Melville, New York 11747
(hereinafter, the "Issuer")
Item 5. Interest in Securities of the Issuer
(a) Prior to March 16, 2000, the Trust was the beneficial
owner of 980,000 shares of Common Stock of the Issuer
(the "Trust Shares"), representing 6.65% of the
Issuer's Common Stock. The Trust has sold a total of
76,000 of the Trust Shares in a series of related
transactions described in item 5(c) below.
(c) In a series of related transactions, concluding on
March 16, 2000, the Trust sold 76,000 shares of the
Issuer's Common Stock for cash at an average price
per share equal to $0.93. Such transactions were made
pursuant to Rule 144.
Item 6. Contracts, Arrangements, Understandings of Relationships With Respect
to Securities of the Issuer
None.
Item 7. Exhibits
None
Page 3 of 4 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
March 31, 2000 By: /s/ Eric Rainer Bashford
- ---------------------- --------------------------------
Date Eric Rainer Bashford
Page 4 of 4 Pages
